These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31830113)

  • 1. Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.
    Wernberg CW; Schaffalitzky de Muckadell OB; Vilstrup H; M Lauridsen M
    PLoS One; 2019; 14(12):e0226283. PubMed ID: 31830113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests.
    Lauridsen MM; Schaffalitzky de Muckadell OB; Vilstrup H
    Metab Brain Dis; 2015 Oct; 30(5):1187-92. PubMed ID: 26016624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
    Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
    Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of HE history, HE status and neuropsychological test type on learning ability in patients with cirrhosis.
    Zarantonello L; Turco M; Formentin C; Izquierdo-Altarejos P; Vuerich A; Barcenas Jimenez MJ; Montoliu C; Felipo V; Angeli P; Amodio P; Montagnese S
    Liver Int; 2019 May; 39(5):861-870. PubMed ID: 30658006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy.
    Lauridsen MM; Poulsen L; Rasmussen CK; Høgild M; Nielsen MK; de Muckadell OB; Vilstrup H
    Metab Brain Dis; 2016 Apr; 31(2):267-72. PubMed ID: 26435407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 6 tests for diagnosing minimal hepatic encephalopathy and predicting clinical outcome: A prospective, observational study.
    Ehrenbauer AF; Egge JFM; Gabriel MM; Tiede A; Dirks M; Witt J; Wedemeyer H; Maasoumy B; Weissenborn K
    Hepatology; 2024 Aug; 80(2):389-402. PubMed ID: 38349709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
    Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
    J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.
    Lauridsen MM; Mikkelsen S; Svensson T; Holm J; Klüver C; Gram J; Vilstrup H; Schaffalitzky de Muckadell OB
    PLoS One; 2017; 12(10):e0185412. PubMed ID: 29020023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
    Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
    Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
    J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation.
    Acharya C; Wade JB; Fagan A; White M; Gavis E; Ganapathy D; Gilles H; Heuman DM; Bajaj JS
    Liver Transpl; 2017 Nov; 23(11):1396-1403. PubMed ID: 28885772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study.
    Huang CH; Yu TY; Tseng WJ; Huang YT; Chang SH; Hsieh SY; Chien RN; Amodio P
    Ann Med; 2023 Dec; 55(1):2236013. PubMed ID: 37494454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
    Bajaj JS; Schubert CM; Heuman DM; Wade JB; Gibson DP; Topaz A; Saeian K; Hafeezullah M; Bell DE; Sterling RK; Stravitz RT; Luketic V; White MB; Sanyal AJ
    Gastroenterology; 2010 Jun; 138(7):2332-40. PubMed ID: 20178797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival.
    Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Lok AS; Sultanik P; Galle PR; Labenz J; Thabut D; Marquardt JU; Bloom PP; Lauridsen MM; Montagnese S; Nardelli S; Labenz C
    J Intern Med; 2024 Mar; 295(3):331-345. PubMed ID: 37983845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
    Bajaj JS; Heuman DM; Sterling RK; Sanyal AJ; Siddiqui M; Matherly S; Luketic V; Stravitz RT; Fuchs M; Thacker LR; Gilles H; White MB; Unser A; Hovermale J; Gavis E; Noble NA; Wade JB
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1828-1835.e1. PubMed ID: 24846278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.
    Bajaj JS; Thacker LR; Heuman DM; Fuchs M; Sterling RK; Sanyal AJ; Puri P; Siddiqui MS; Stravitz RT; Bouneva I; Luketic V; Noble N; White MB; Monteith P; Unser A; Wade JB
    Hepatology; 2013 Sep; 58(3):1122-32. PubMed ID: 23389962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis.
    Barone M; Shahini E; Iannone A; Viggiani MT; Corvace V; Principi M; Di Leo A
    Dig Liver Dis; 2018 May; 50(5):496-500. PubMed ID: 29530628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing.
    Duarte-Rojo A; Allampati S; Thacker LR; Flud CR; Patidar KR; White MB; Klair JS; Heuman DM; Wade JB; Gavis EA; Bajaj JS
    Metab Brain Dis; 2019 Feb; 34(1):289-295. PubMed ID: 30506333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.